Logo

America Pharma Source, Ambion

Mar 09, 2006
Premium

America Pharma Source has recently introduced a new in vitro lipid transfection reagent, Cellipon293.

According to the company, the reagent is specifically developed for the delivery of DNA/RNA into HEK293 cells as well as a broad range of mammalian cells.

Ambion recently introduced the Silencer siRNA starter kit.

According to the company, the kit provides all of the reagents, protocols, and instructions necessary for siRNA transfection and gene knockdown experiments.

Filed under

Gene Silencing/Gene Editing
RNAi
Breaking News
The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.